DMT.V - Small Pharma Inc.

TSXV - TSXV Real Time Price. Currency in CAD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-02-28
2021-02-28
Total Revenue
0
0
77.643
Operating Expenses
Research Development
10,004
4,828
1,920
Selling General and Administrative
15,880
13,104
3,772
Total Operating Expenses
25,907
17,952
5,699
Operating Income or Loss
-25,907
-17,952
-5,621
Interest Expense
-32.717
433.732
484.895
Total Other Income/Expenses Net
-44.633
-4,535
-922.656
Income Before Tax
-25,908
-22,921
-7,029
Income Tax Expense
-655.166
-655.166
6.723
Income from Continuing Operations
-25,253
-22,266
-7,035
Net Income
-25,253
-22,266
-7,035
Net Income available to common shareholders
-25,253
-22,266
-7,035
Basic EPS
-
-0.07
-0.02
Diluted EPS
-
-0.07
-0.02
Basic Average Shares
-
311,600
316,800
Diluted Average Shares
-
311,600
316,800
EBITDA
-
-22,467
-6,538